Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
semaglutide/nad Microdosing Semaglutide: Does It Work for Weight Loss? Why are GLP1 Drugs Size:Single Stick Health Needs_Gut Health
Why are GLP1 Drugs So Expensive? The Complex World of PBMs with Josh Sanders, PharmD
[Accessed 12 August 2026] National Institute for Health and Care Excellence (NICE)
Health Needs_Gut Health
Size:Single Stick
Dual and multi-receptor obesity peptide comparison (June 2026) Peptide Survodutide (BI 456906) Receptor targets GLP-1 + Glucagon Top reported weight loss 16.6% (Phase 3 SYNCHRONIZE-1, 76 weeks) Route Subcutaneous, once weekly FDA status Investigational Peptide Retatrutide Receptor targets GLP-1 + GIP + Glucagon (triple) Top reported weight loss 24.2% (Phase 2, 48 weeks) Route Subcutaneous, once weekly FDA status Investigational Peptide Tirzepatide (Mounjaro / Zepbound) Receptor targets GLP-1 + GIP Top reported weight loss 20.9% (SURMOUNT-1, 72 weeks) Route Subcutaneous, once weekly FDA status FDA-approved (T2D and obesity) Peptide Semaglutide (Ozempic / Wegovy / Rybelsus) Receptor targets GLP-1 only Top reported weight loss 14.9% (STEP 1, 68 weeks) Route Subcutaneous, once weekly (oral Rybelsus daily) FDA status FDA-approved (T2D and obesity) Peptide CagriSema (cagrilintide + semaglutide) Receptor targets GLP-1 + Amylin Top reported weight loss 22.7% (REDEFINE-1 Phase 3) Route Subcutaneous, once weekly FDA status Investigational Numbers are from each peptide's primary trial
US$ 25.37
US$ 26.44
US$ 29.36
US$ 29.39
US$ 23.61
US$ 26.53
US$ 21.78
US$ 29.50
US$ 20.73
US$ 26.11
US$ 24.42
